Huirong Xie heads the embryo manipulation program at MSU’s Transgenic Genomic Editing Facility (TGEF). She is an expert in all reproductive biology techniques required for genome editing, including embryo microinjection and electroporation.
Dr. Xie completed her Ph.D. in reproductive endocrinology at China Agricultural University, and conducted her postdoctoral work at Vanderbilt University Medical Center and Cincinnati Children’s Hospital Medical Center. Prior to joining MSU, Dr. Xie was a key member of the transgenic facility at CCHMC that has successfully generated over 100 animal lines by CRISPR/Cas editing.
Dr. Xie assist investigators with projects requiring genome editing in a variety of model systems, from the design to animal generation stage. She also runs the MSU-TGEF cryopreservation program and provides cryo-related consultation and services. Her current research and development efforts at MSU-TGEF focus on optimizing CRISPR/Cas efficiency in rodents and pioneering non-rodent gene editing and embryo manipulation approaches.